• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchGracell Biotechnologies
    Picture of Gracell Biotechnologies logo

    GRCL — Gracell Biotechnologies News Story

    $10.140.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapNeutral
    • Market Cap
      $972.69m
    • Enterprise Value
      $750.11m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • GRCL Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    GRCL Dividends
    All News

    NASDAQ RESUMED AT 09:51 AM

    Picture of Gracell Biotechnologies logoGracell Biotechnologies
    23/11/2021 14:51
    NASDAQ RESUMED  GRCL.O  AT 09:51 AM
    

    Recent news on Gracell Biotechnologies

    See all news
    • Brief: Gracell Biotechnologies Announces Shareholders’ Approval Of Merger Agreement

      20/02/2024 13:26
    • Brief: Gracell Biotechnologies Announces FDA Clearance of IND Application for Phase 1 Clinical Trial of FasTCAR-T GC012F as Early-Line Treatment of Multiple Myeloma

      29/01/2024 14:04
    • Newscasts - UK Day Ahead: European shares start last week of 2023 on strong footing

      27/12/2023 15:30
    • Live Markets: European futures rise after holiday break

      27/12/2023 07:42
    • Press Digest: British Business - Dec 27

      27/12/2023 24:14

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.